Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 76483-112

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 76483-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Square Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine Orally Disintegrating Tablets Usp, 15 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 01)

This is a description of a medication called Mirtazapine Orally Disintegrating Tablets, USP available in blister packs of 5 with 30 tablets. The medication is to be stored at 20-25°C (68-77°F) away from light and moisture. The purpose or instructions for taking the medication are not available in the given text.*

FDA Label Image

Mirtazapine Orally Disintegrating Tablets Usp, 30 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 02)

This appears to be a package insert or label for a medication called Mirtazapine Orally Disintegrating Tablets. It includes dosage information, manufacturer information, and warnings about keeping the medication out of reach of children. The text is not well-formatted and is missing key information, so this description may not be comprehensive.*

FDA Label Image

Mirtazapine Orally Disintegrating Tablets Usp, 45 mg (B24e0ecd 3a9d 4515 8c84 382de235c65b 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.